New Program Available – Please click here to download the Preliminary FH and Genetics Satellite Meeting Program.
The key aim of FH and Genetic Dyslipidaemia Satellite to the ISA2012 meeting is to provide a comprehensive, state-of-the-art overview of issues ranging from molecular science to clinical care.
Presentations will focus on recent clinical and scientific advances in key and emerging areas including:
- Case finding and clinical assessment of FH
- Genetic control of Apo B secretion and function
- Laboratory diagnosis and assessment of FH
- Genetic control of HDL and reverse cholesterol transport
- Genes and Geography: Continental lessons in genetic dyslipidaemia
- The logistics of cascade screening
- Detecting and explaining novel genetic causes of dyslipidaemia
- Genes affecting triglyceride and thrombophyllia
- Lipoprotein (a) and apo (a)
- Novel therapies for genetic dyslipidaemia
- Current and future challenges
